California State Teachers Retirement System (CalSTRS)
TRVI icon

California State Teachers Retirement System (CalSTRS)’s Trevi Therapeutics TRVI Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
108,004
+24,613
+30% +$358K ﹤0.01% 1595
2026
Q1 		$995K Sell
83,391
-397
-0.5% -$4.45K ﹤0.01% 1813
2025
Q4 		$1.05M Buy
83,788
+2,091
+3% +$24.2K ﹤0.01% 1776
2025
Q3 		$748K Buy
81,697
+77,200
+1,717% +$579K ﹤0.01% 1917
2025
Q2 		$24.6K Hold
4,497
– – ﹤0.01% 2437
2025
Q1 		$28.3K Hold
4,497
– – ﹤0.01% 2430
2024
Q4 		$18.5K Buy
4,497
+242
+6% +$775 ﹤0.01% 2639
2024
Q3 		$14.2K Hold
4,255
– – ﹤0.01% 2759
2024
Q2 		$12.7K Buy
4,255
+18
+0.4% +$50 ﹤0.01% 2788
2024
Q1 		$14.6K Sell
4,237
-2,701
-39% -$6.03K ﹤0.01% 2836
2023
Q4 		$9.3K Sell
6,938
-2,247
-24% -$3.4K ﹤0.01% 3010
2023
Q3 		$20K Sell
9,185
-4,663
-34% -$10.5K ﹤0.01% 2980
2023
Q2 		$33.1K Buy
+13,848
New +$34.9K ﹤0.01% 3023

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s TRVI Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Trevi Therapeutics (TRVI) stake by 30% in Q2 2026, buying an estimated $358K and bringing the position to 108,004 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

California State Teachers Retirement System (CalSTRS) first reported a position in TRVI in Q2 2023 and has held it in 13 quarters since. 217 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 108,004 shares of Trevi Therapeutics worth $2.01M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 24,613 Trevi Therapeutics shares in Q2 2026, an estimated $358K.
  • Trevi Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1595 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Trevi Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • 217 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.